These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling. Aleixandre V; Urios A; Herrera G; Blanco M Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316 [TBL] [Abstract][Full Text] [Related]
3. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424 [TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005 [TBL] [Abstract][Full Text] [Related]
5. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897 [TBL] [Abstract][Full Text] [Related]
6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012 [TBL] [Abstract][Full Text] [Related]
7. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Yoshida H; Bogaki M; Nakamura M; Nakamura S Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148 [TBL] [Abstract][Full Text] [Related]
8. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Bagel S; Hüllen V; Wiedemann B; Heisig P Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193 [TBL] [Abstract][Full Text] [Related]
9. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760 [TBL] [Abstract][Full Text] [Related]
10. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409 [TBL] [Abstract][Full Text] [Related]
11. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms. Howard BM; Pinney RJ; Smith JT Microbios; 1994; 77(311):121-31. PubMed ID: 8152392 [TBL] [Abstract][Full Text] [Related]
12. Quinolone mode of action--new aspects. Hooper DC Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456 [TBL] [Abstract][Full Text] [Related]
13. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity. Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091 [TBL] [Abstract][Full Text] [Related]
14. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene. Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of and resistance to ciprofloxacin. Hooper DC; Wolfson JS; Ng EY; Swartz MN Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA. Masecar BL; Robillard NJ Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance. Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537 [TBL] [Abstract][Full Text] [Related]
18. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Cambau E; Bordon F; Collatz E; Gutmann L Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306 [TBL] [Abstract][Full Text] [Related]